9. In a letter dated September 3, 2021, the Respondent informed the Facility
that he was resigning his privileges.

10. On or about November 4, 2021, the Facility submitted the evaluation report
to the Board. As a result, the Board initiated an investigation of the Respondent.
Respondent's written response

ll. After receiving this information, the Board requested that the Respondent
address the circumstances of his resignation from the Facility in a written response. By
letter dated November 9, 2021, the Respondent acknowledged resigning from the
Facility, before which he had been on a leave of absence. The Respondent stated that at
the time of his resignation, he was the subject of a Facility inquiry into whether he was
engaging in activities that were “not allowed during . . . [his]... leave of absence.” The
Respondent stated that during his leave of absence, he continued to lecture on pediatric
dermatology issues to residents, students, and faculty for teaching purposes at various
health care facilities but was under the impression that his input was informal and not in
the nature of an official consultation.

Board interviews

12. The Board interviewed several former and recent professional colleagues of
the Respondent who made observations about the Respondent’s clinical actions and
behaviors while on staff at the Facility. Those colleagues described instances where the
Respondent: expressed confusion about which patient he was seeing; repeated himself:
performed procedures without appropriate indication; misused or employed inappropriate

treatment modalities; treated patients without an established physician-patient

4
